Researchers say the results are encouraging but also shared cautions. More than half of children in early stages of an ongoing study were able to eat a food they were allergic to one year after ...
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
THE WOODLANDS, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) today announced the completion of patient enrollment in the PROGRESS (A Phase 2b, Dose-ranging, Randomized, ...
New results from a study of a drug called Gazyva (obinutuzumab) showed that it significantly reduced disease activity in adults with systemic lupus erythematosus (SLE). The drug was developed by ...
A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback